Bioforce Nanosciences Holdings Stock Today
| BFNH Stock | USD 0.51 0.07 12.07% |
Performance0 of 100
| Odds Of DistressLess than 46
|
BioForce Nanosciences is trading at 0.51 as of the 29th of December 2024. This is a 12.07 percent decrease since the beginning of the trading day. The stock's open price was 0.58. BioForce Nanosciences has 46 percent odds of going through some form of financial distress in the next two years and has generated negative returns to investors over the last 90 days. The performance scores are derived for the period starting the 29th of November 2024 and ending today, the 29th of December 2024. Click here to learn more.
BioForce Nanosciences Holdings, Inc. focuses on providing natural vitamins, minerals, other nutritional supplements, powders, and beverages for individuals in various age ranges. It sells its nutrition supplements to retailers, sporting goods retailers, supermarkets, and mass merchandisers under the BioForce Eclipse brand, as well as through online and telemarketing. The company has 29.27 M outstanding shares. More on BioForce Nanosciences Holdings
Moving against BioForce Pink Sheet
| 0.57 | K | Kellanova Earnings Call This Week | PairCorr |
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
BioForce Pink Sheet Highlights
| Business Concentration | Packaged Foods, Consumer Defensive (View all Sectors) |
BioForce Nanosciences Holdings [BFNH] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 72.74 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate BioForce Nanosciences's market, we take the total number of its shares issued and multiply it by BioForce Nanosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. BioForce Nanosciences conducts business under Consumer Defensive sector and is part of Packaged Foods industry. The entity has 29.27 M outstanding shares.
BioForce Nanosciences Holdings currently holds about 9.23 K in cash with (77.77 K) of positive cash flow from operations.
Check BioForce Nanosciences Probability Of Bankruptcy
Ownership AllocationBioForce Nanosciences holds a total of 29.27 Million outstanding shares. BioForce Nanosciences Holdings shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 82.29 percent of BioForce Nanosciences outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check BioForce Ownership Details
BioForce Nanosciences Risk Profiles
| Mean Deviation | 3.71 | |||
| Standard Deviation | 7.5 | |||
| Variance | 56.21 | |||
| Risk Adjusted Performance | (0.1) |
BioForce Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in BioForce Nanosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Equity Analysis Now
Equity AnalysisResearch over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |
| All Next | Launch Module |
BioForce Nanosciences Corporate Management
| Steven Gagnon | CoChief Officer | Profile | |
| Richard Kaiser | Corp CFO | Profile | |
| Aleksandr Shapiro | President | Profile | |
| John LaViolette | CoChief Officer | Profile |
Other Information on Investing in BioForce Pink Sheet
BioForce Nanosciences financial ratios help investors to determine whether BioForce Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioForce with respect to the benefits of owning BioForce Nanosciences security.